  Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphomaMalaise, Olivier  ; FRUSCH, Nicolas ; BECK, Emmanuel et alin Leukemia & Lymphoma (2012), 53(12), 2515-16 Detailed reference viewed: 20 (5 ULg)L'image du mois. Agenesie de l'artere pulmonaire droite associee a une hypoplasie du poumon droit.FRUSCH, Nicolas ; DUYSINX, Bernard ; BLEUS, Nicolas et alin Revue Médicale de Liège (2012), 67(1), 4 Detailed reference viewed: 23 (10 ULg)Y a-t-il une place pour les β-bloquants dans les maladies pulmonaires obstructives ?; FRUSCH, Nicolas ; DUYSINX, Bernard et alin Revue Médicale de Liège (2011), 66(12), 619-623 Detailed reference viewed: 15 (3 ULg)L'image du mois. Geyser endobronchique secondaire a une fistule broncho-oesophagienne.DUYSINX, Bernard ; HEINEN, Vincent ; FRUSCH, Nicolas et alin Revue Médicale de Liège (2011), 66(10), 511-2 Detailed reference viewed: 5 (0 ULg)Pneumopathies organisées: à propos de 3 cas; Frusch, Nicolas ; Louis, Renaud et alin Revue Médicale de Liège (2010), 65(10), 549-55 Infiltrative lung lesions are not always linked to infectious processes or cancers. An interesting entity, the OP (Organizing Pneumonia) or COP (Cryptogenic Organizing Pneumonia)--formerly BOOP ... [more ▼] Infiltrative lung lesions are not always linked to infectious processes or cancers. An interesting entity, the OP (Organizing Pneumonia) or COP (Cryptogenic Organizing Pneumonia)--formerly BOOP (Bronchiolitis Obliterans Organizing Pneumonia)--is discussed through observations repor. ted in this article. We provide some keys to allow the astute observer to target this often curable disease. [less ▲] Detailed reference viewed: 28 (3 ULg) Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphomaServais, Sophie ; Caers, Jo ; et alin British Journal of Haematology (2010), 150(3), 379-381 Detailed reference viewed: 19 (6 ULg)Prise en charge du cancer pulmonaire non a petites cellulesBosquee, Léon ; Frusch, Nicolas ; Louis, Renaud in Revue Médicale Suisse (2007), 3(122), 1890-5 Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment of non small cell lung cancer. Surgery is the cornerstone of the stages I-II treatment; chemotherapy is ... [more ▼] Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment of non small cell lung cancer. Surgery is the cornerstone of the stages I-II treatment; chemotherapy is dominant in the treatment of metastatic stage, but is more and more used in earlier stages. A large discussion is still open for advanced non metastatic stages, even if the association of the 3 major modalities is extensively studied. We discuss our position in this setting. [less ▲] Detailed reference viewed: 114 (5 ULg)Le cancer du poumon. Epidemiologie et facteurs etiologiques.Frusch, Nicolas ; Bosquee, Léon ; Louis, Renaud in Revue Médicale de Liège (2007), 62(9), 548-53 Lung cancer is the most frequent cause of death by cancer worldwide. Despite improvements in the treatment the vital prognosis remains poor with an estimated 5-year survival rate of 15 % all stages ... [more ▼] Lung cancer is the most frequent cause of death by cancer worldwide. Despite improvements in the treatment the vital prognosis remains poor with an estimated 5-year survival rate of 15 % all stages together. Even if some environmental exposure may favour apparition of the disease, tobacco smoking is by far the greatest risk factor for developing lung cancer. Recent progresses have been made on the identification of cellular mechanisms and genetic abnormalities that make the patients more prone to develop lung cancer. [less ▲] Detailed reference viewed: 243 (12 ULg) |
||
